… for these PET biomarkers, … diseases that can lead to dementia. We propose three main
diagnostic pathways with distinct biomarker sequences, in which amyloid-PET and 18 F-FDG-PET …

… PET imaging agents such as PiB, and imaging AD neurodegenerative processes, using FDG
PET … or perhaps preclinical detection of disease and accurately distinguishing AD from non-…

… FDGPET abnormalities were observed up to 13 years prior to … pathology [12], FDG-PET
studies have identified a similar … of the age at onset of disease. More studies are needed to …

… We report the first clinicopathological series of longitudinal FDG-PET scans in post-mortem
(PM) verified cognitively normal elderly (NL) followed to the onset of Alzheimer’s-type …

… Moreover, to our knowledge, there are no 18 F-FDG PET studies comparing MCI with … As
18 F-FDG PET measures were the outcome measure in this study, 18 F-FDG PET findings were …

… of 88% between patients with Alzheimer's disease and elderly healthy controls, and 65% …
to Alzheimer's disease. We demonstrate that information extracted from serial FDG-PET …

… Awaiting replication in an independent sample, these findings suggest that among
patients with MCI, fluorodeoxyglucose PET may accurately identify rapid converters. …

… the diagnosis of Alzheimer disease from fluorine 18 fluorodeoxyglucose PET of the brain.
■ A deep learning algorithm can be used as an early prediction tool for Alzheimer disease, …

… Moreover, recent MRI-guided FDG-PET studies have shown that MTL hypometabolism is …
and longitudinal FDG-PET studies and attempts to put into perspective the value of FDG-PET in …

… Alzheimer's Disease Centers served as raters (SA, NB, CC, CD, WJ and RST). FDG-PET …
experience; some were recognized experts in FDG-PET imaging, others were novices. We …